Sikic BI - Search Results

1

Antibody-directed targeting of liposomes to human cell lines: role of binding and internalization on growth inhibition.

Berinstein N, Matthay KK, Papahadjopoulos D, Levy R, Sikic BI. Berinstein N, et al. Among authors: sikic bi. Cancer Res. 1987 Nov 15;47(22):5954-9. Cancer Res. 1987. PMID: 3664498

2

Enhancement of the clinical activity of melphalan by the hypoxic cell sensitizer misonidazole.

Coleman CN, Carlson RW, Artim RA, Sampson WI, Lawrence HJ, Wong P, Halsey J, Kohler M, Gribble M, Sikic BI, et al. Coleman CN, et al. Among authors: sikic bi. Cancer Res. 1988 Jun 15;48(12):3528-32. Cancer Res. 1988. PMID: 2836059 Clinical Trial.

3

Paradoxical increase in DNA cross-linking in a human ovarian carcinoma cell line resistant to cyanomorpholino doxorubicin.

Lau DH, Ross KL, Sikic BI. Lau DH, et al. Among authors: sikic bi. Cancer Res. 1990 Jul 1;50(13):4056-60. Cancer Res. 1990. PMID: 2162251

4

Reversal by cefoperazone of resistance to etoposide, doxorubicin, and vinblastine in multidrug resistant human sarcoma cells.

Gosland MP, Lum BL, Sikic BI. Gosland MP, et al. Among authors: sikic bi. Cancer Res. 1989 Dec 15;49(24 Pt 1):6901-5. Cancer Res. 1989. PMID: 2582432

5

Role of cytochrome P-450 from the human CYP3A gene family in the potentiation of morpholino doxorubicin by human liver microsomes.

Lewis AD, Lau DH, Durán GE, Wolf CR, Sikic BI. Lewis AD, et al. Among authors: sikic bi. Cancer Res. 1992 Aug 15;52(16):4379-84. Cancer Res. 1992. PMID: 1643634

6

Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.

Lau DH, Lewis AD, Ehsan MN, Sikic BI. Lau DH, et al. Among authors: sikic bi. Cancer Res. 1991 Oct 1;51(19):5181-7. Cancer Res. 1991. PMID: 1717140

7

Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol).

Dumontet C, Duran GE, Steger KA, Beketic-Oreskovic L, Sikic BI. Dumontet C, et al. Among authors: sikic bi. Cancer Res. 1996 Mar 1;56(5):1091-7. Cancer Res. 1996. PMID: 8640766

8

DNA cross-linking and cytotoxicity of the alkylating cyanomorpholino derivative of doxorubicin in multidrug-resistant cells.

Scudder SA, Brown JM, Sikic BI. Scudder SA, et al. Among authors: sikic bi. J Natl Cancer Inst. 1988 Oct 19;80(16):1294-8. doi: 10.1093/jnci/80.16.1294. J Natl Cancer Inst. 1988. PMID: 3172256

9

Prevalence of multidrug resistance related to activation of the mdr1 gene in human sarcoma mutants derived by single-step doxorubicin selection.

Chen KG, Jaffrézou JP, Fleming WH, Durán GE, Sikic BI. Chen KG, et al. Among authors: sikic bi. Cancer Res. 1994 Sep 15;54(18):4980-7. Cancer Res. 1994. PMID: 7915196

10

Volume-activated chloride current is not related to P-glycoprotein overexpression.

Dong Y, Chen KG, Durán GE, Kouyama K, Chao AC, Sikic BI, Gollapudi SV, Gupta S, Gardner P. Dong Y, et al. Among authors: sikic bi. Cancer Res. 1994 Oct 1;54(19):5029-32. Cancer Res. 1994. PMID: 7923110

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters